To include your compound in the COVID-19 Resource Center, submit it here.

GSK relaxing IP approach in poorer countries

On a conference call Thursday, CEO Andrew Witty said GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) is taking steps to align its patent filing and enforcement policies with various nations' levels of "economic

Read the full 309 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE